购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Apoptosis
    (2)
  • RAAS
    (2)
  • AChR
    (1)
  • Bcl-2 Family
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (5)
  • 5日内发货
    (8)
  • 6-8周
    (3)
  • 8-10周
    (1)
筛选
搜索结果
TargetMol产品目录中 "

hepatic enzyme

"的结果
  • 抑制剂&激动剂
    14
    TargetMol | Inhibitors_Agonists
  • 重组蛋白
    8
    TargetMol | Recombinant_Protein
  • 天然产物
    2
    TargetMol | Natural_Products
  • LM10
    T44101316695-35-8
    LM10 是有效的色氨酸 2,3-双加氧酶的抑制剂。色氨酸 2,3-双加氧酶是一种无关的肝酶,它可通过犬尿氨酸途径降解色氨酸。它对研究癌症疾病具有潜在的研究价值。
    • ¥ 118
    现货
    规格
    数量
    TargetMol | Inhibitor Sale
  • Docetaxel trihydrate
    多西他赛三水合物, RP-56976 (Trihydrate), RP56976 (NSC 628503) Trihydrate
    T0186148408-66-6
    Docetaxel trihydrate (RP-56976 Trihydrate) 是一种抗肿瘤试剂,抑制微管解聚的IC50值为 0.2 μM。它是紫杉醇的半合成类似物,能减弱 bcl-2 和 bcl-xL 基因表达的影响。它阻滞G2 M 细胞周期,导致细胞凋亡。
    • ¥ 327
    现货
    规格
    数量
  • D-Glucaric acid potassium
    D-葡萄糖二酸单钾盐
    T4916576-42-1
    D-Glucaric acid potassium (D-Saccharic acid potassium salt) 是内源性代谢产物的一种。
    • ¥ 119
    现货
    规格
    数量
  • Peimisine
    Ebeiensine, 贝母辛
    T5S010619773-24-1
    Peimisine (Ebeiensine) 非竞争性拮抗气管平滑肌 M 受体,抑制 Ach 引起的平滑肌收缩。它兴奋 β 受体和拮抗内钙释放,促进一氧化氮释放,可舒张气管平滑肌,有平喘作用。
    • ¥ 333
    现货
    规格
    数量
    TargetMol | Inhibitor Sale
  • (R)-3-Hydroxy Midostaurin
    (R)-CGP52421
    T12610155848-20-7
    (R)-3-Hydroxy Midostaurin is a potent inhibitor of kinases,is a major metabolite of midostaurin undergoing by the hepatic CYP3A4 enzyme,has the potential for acute myeloid leukemia (AML).
    • 待询
    3-6月
    规格
    数量
  • Flumecinol
    Zyxorin
    T3181556430-99-0
    Flumecinol is a hepatic enzyme (cytochrome P-450 monooxygenases) inducer.
    • ¥ 10600
    6-8周
    规格
    数量
  • Debutyldronedarone hydrochloride
    SR35021 hydrochloride
    T35712197431-02-0
    N-Desbutyl dronedarone is an active metabolite of the antiarrhythmic agent dronedarone .1,2,3It is formed from dronedarone by cytochrome P450s (CYPs) and monoamine oxidase (MAO) in human hepatocyte preparations.4N-Desbutyl dronedarone inhibits the binding of 3,3’,5-triiodo-L-thyronine to the thyroid hormone receptors TRα1and TRβ1(IC50s = 59 and 280 μM for the chicken and human receptors, respectively).1It inhibits CYP2J2-mediated formation of 14,15-EET from arachidonic acid and soluble epoxide hydrolase-mediated formation of 14,15-DHET from 14,15-EET (IC50s = 1.59 and 2.73 μM, respectively, in cell-free assays).2N-Desbutyl dronedarone decreases intracellular ATP levels in H9c2 rat cardiomyocytes (IC50= 1.07 μM) and inhibits mitochondrial complex I, also known as NADH dehydrogenase, and mitochondrial complex II, also known as succinate dehydrogenase, activities in isolated rat heart mitochondria (IC50s = 11.94 and 24.54 μM, respectively).3 1.Van Beeren, H.C., Jong, W.M.C., Kaptein, E., et al.Dronerarone acts as a selective inhibitor of 3,5,3’-triiodothyronine binding to thyroid hormone receptor-α1: in vitro and in vivo evidenceEndocrinology144(2)552-558(2003) 2.Karkhanis, A., Tram, N.D.T., and Chan, E.C.Y.Effects of dronedarone, amiodarone and their active metabolites on sequential metabolism of arachidonic acid to epoxyeicosatrienoic and dihydroxyeicosatrienoic acidsBiochem. Pharmacol.146188-198(2017) 3.Karkhanis, A., Leow, J.W.H., Hagen, T., et al.Dronedarone-induced cardiac mitochondrial dysfunction and its mitigation by epoxyeicosatrienoic acidsToxicol. Sci.163(1)79-91(2018) 4.Klieber, S., Arabeyre-Fabre, C., Moliner, P., et al.Identification of metabolic pathways and enzyme systems involved in the in vitro human hepatic metabolism of dronedarone, a potent new oral antiarrhythmic drugPharmacol. Res. Perspec.2(3)e00044(2014)
      5日内发货
      询价
    • hiv-1 inhibitor-16
      T621292719675-72-4
      HIV-1 inhibitor-16 (compound 7a) 是一种高效的 HIV-1抑制剂,对野生型 HIV-1 的 EC50为 1.3 nM。HIV-1 inhibitor-16 对 HIV-1 K103N、E138K、Y181C 和 L100I 病毒株也有一定的抑制活性,EC50分别为 5.4 nM、9.2 nM、22 nM 和 35 nM。HIV-1 inhibitor-16 具有良好的溶解性和肝微粒体稳定性,未表现出明显的 CYP 酶抑制活性或急性毒性。
      • ¥ 10600
      6-8周
      规格
      数量
    • Moexipril hydrochloride
      莫昔普利盐酸盐, SPM 925, RS-10085, Moexipril HCl, CI-925
      T659582586-52-5
      Moexipril hydrochloride (Moexipril HCl) 是一种有口服活性的,不含巯基的血管紧张素转化酶抑制剂,可治疗高血压和充血性心力衰竭。
      • ¥ 118
      期货
      规格
      数量
      TargetMol | Inhibitor Sale
    • Cinnamic acid, hydrazide
      T693803538-69-0
      Cinnamic acid, hydrazide is an unsaturated carboxylic acid and precursor to aspartame via enzyme-catalysed amination to phenylalanine. Cinnamic acid may be useful in prevention or treatment of Diabetes through various mechanism of actions including stimulation of insulin secretion, improvement of pancreatic β-cell functionality, inhibition of hepatic gluconeogenesis, enhanced glucose uptake, increased insulin signaling pathway, delay of carbohydrate digestion and glucose absorption, and inhibition of protein glycation and insulin fibrillation.
      • ¥ 10600
      6-8周
      规格
      数量
    • Nedosiran sodium
      T739942247026-22-6
      Nedosiran sodium 是一种靶向乳酸脱氢酶 (LDH)的 RNA 干扰剂 (RNAi)。Nedosiran sodium?可用于研究并发终末期肾病 (ESRD)的原发性高草酸尿症 (PH)。
      • 待询
      规格
      数量
    • Glucagon (Human)
      Hyperglycemic-glycogenolytic factor, Glukagon
      T780599007-92-5
      Glucagon 对蛋白质和氨基酸的代谢产生显著的调节作用。它抑制了氨基酸与肝脏、肌肉以及胰腺蛋白的结合,增加氮的排出,并促进肝脏内尿素的合成。同时,Glucagon 增加了肝脏中转氨酶和尿素循环酶的浓度,提高了肝脏对氨基酸的摄取,并加强了氨基酸与肝糖原之间的结合,从而降低了血液中的氨基酸浓度。
      • 待询
      规格
      数量
    • Anti-hepatic fibrosis agent 2
      T830642380421-60-1
      Fibrosis agent 2为针对Ewing肉瘤断点区域1 (EWSR1) 的特定抗纤维化化合物。
      • 待询
      8-10周
      规格
      数量
    • ELOVL6-IN-5
      T879731135000-36-0
      ELOVL6-IN-5(compound B)是针对ELOVL6的抑制剂,后者为长链脂肪酸家族6的延长酶,负责饱和及单不饱和长链脂肪酸的延长,并且是糖尿病治疗中的有效靶点。此化合物能在饮食诱导肥胖(DIO)的小鼠模型中有效降低肝脏脂肪酸水平,尽管如此,通过ELOVL6-IN-5引起的ELOVL6抑制并未改善胰岛素抵抗问题。
      • 待询
      10-14周
      规格
      数量
    没有更多数据了